Showing results (401-410 of 635) with videos related to
Sort By:
Pageof 64
Briefings in Bioinformatics|May 10, 2021
Knowledge bases and software support for variant interpretation in precision oncologyFlorian Borchert, Andreas Mock, Aurelie Tomczak, et al.Cancer Immunology, Immunotherapy : CII|December 23, 2022
BAP1 and PTEN mutations shape the immunological landscape of clear cell renal cell carcinoma and reveal the intertumoral heterogeneity of T cell suppression: a proof-of-concept studyJana Friedhoff, Felix Schneider, Christina Jurcic, et al.Oncotarget|August 14, 2014
Targeted ultra-deep sequencing reveals recurrent and mutually exclusive mutations of cancer genes in blastic plasmacytoid dendritic cell neoplasmAlbrecht Stenzinger, Volker Endris, Nicole Pfarr, et al.Genes, Chromosomes & Cancer|April 24, 2016
Pan-cancer analysis of copy number changes in programmed death-ligand 1 (PD-L1, CD274) - associations with gene expression, mutational load, and survivalJan Budczies, Michael Bockmayr, Carsten Denkert, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 24, 2006
High-resolution genomic profiling reveals association of chromosomal aberrations on 1q and 16p with histologic and genetic subgroups of invasive breast cancerDaniel E Stange, Bernhard Radlwimmer, Falk Schubert, et al.Genes, Chromosomes & Cancer|July 21, 2016
Tubular, lactating, and ductal adenomas are devoid of MED12 Exon2 mutations, and ductal adenomas show recurrent mutations in GNAS and the PI3K-AKT pathwayAnna-Lena Volckmar, Jonas Leichsenring, Christa Flechtenmacher, et al.Journal of Cancer|September 14, 2020
Mass Spectrometry Imaging Differentiates Chromophobe Renal Cell Carcinoma and Renal Oncocytoma with High AccuracyMark Kriegsmann, Rita Casadonte, Nadine Maurer, et al.Molecular Oncology|February 22, 2023
Targeted therapy of advanced parathyroid carcinoma guided by genomic and transcriptomic profilingMaria-Veronica Teleanu, Carmina T Fuss, Nagarajan Paramasivam, et al.Lung Cancer (Amsterdam, Netherlands)|June 27, 2026
New biomarkers for antibody-drug conjugates in lung cancer the pathologist's perspectiveVéronique Hofman, Guylène Rignol, Baharia Mograbi, et al.International Journal of Cancer|May 30, 2020
Distinct immune evasion in APOBEC-enriched, HPV-negative HNSCCClemens Messerschmidt, Benedikt Obermayer, Konrad Klinghammer, et al.Pageof 64